VSIR and familial pancreatic carcinoma: When comparing immune cell (IC) infiltrates in melanoma and pancreatic cancer, Blando et al. demonstrated that VISTA is preferentially expressed at higher levels in pancreatic cancer, and highlighted this protein as a potential immunotherapeutic target for patients with this disease [12].